ICON's Leadership and Performance in Phase 1 Clinical Trials Recognised in Independent Industry Benchmarking ReportBusiness Wire • 07/16/25
ICON and Its Employees Recognised as Clinical Research Industry Leaders, and for Innovation and Progress in SustainabilityBusiness Wire • 07/07/25
ICON: With A 57% Drop, Trump Legislation, And Debt Reduction, Is The Stock Undervalued?Seeking Alpha • 06/25/25
ICLR Investors Have Opportunity to Lead ICON Public Limited Company Securities Fraud Lawsuit with the Schall Law FirmBusiness Wire • 06/02/25
ICLR Shareholders Have the Right to Lead the ICON Public Limited Company Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - ICLRPRNewsWire • 06/02/25
Global ICON survey shows need for more efficient obesity clinical trial design to realise full potential of next-gen multi-indication therapiesBusiness Wire • 05/07/25
ICLR Investors Have Opportunity to Lead ICON Public Limited Company Securities Fraud Lawsuit with the Schall LAW FIRMPRNewsWire • 05/05/25
ICON Public Limited Company Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before April 11, 2025 to Discuss Your Rights - ICLRAccesswire • 04/11/25
Shareholders of ICON Public Limited Company Should Contact Levi & Korsinsky Before April 11, 2025 to Discuss Your Rights - ICLRAccesswire • 04/11/25
ICLR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that ICON PLC Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitGlobeNewsWire • 04/11/25
ICON PLC Investors: Please contact the Portnoy Law Firm to recover your losses. April 11, 2025 Deadline to file Lead Plaintiff MotionGlobeNewsWire • 04/11/25
FINAL REMINDER ICLR DEADLINE: Bronstein, Gewirtz & Grossman LLC Alerts ICON PLC Investors to Participate in the Class Action LawsuitAccesswire • 04/11/25
Class Action Filed Against ICON Public Limited Company (ICLR) Seeking Recovery for Investors - Contact Levi & KorsinskyPRNewsWire • 04/11/25